| Ident. | Authors (with country if any) | Title |
|---|
| 000806 (2020) |
Giuseppe Magro [Italie] | SARS-CoV-2 and COVID-19: What are our options? Where should we focus our attention on to find new drugs and strategies? |
| 000817 (2020) |
Mathieu Gendrot [France] ; Julien Andreani [France] ; Manon Boxberger [France] ; Priscilla Jardot [France] ; Isabelle Fonta [France] ; Marion Le Bideau [France] ; Isabelle Duflot [France] ; Joel Mosnier [France] ; Clara Rolland [France] ; Hervé Bogreau [France] ; Sébastien Hutter [France] ; Bernard La Scola [France] ; Bruno Pradines [France] | Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation. |
| 000838 (2020) |
Seema Rani [Inde] ; Sandeep Grover [Inde] ; Aseem Mehra [Inde] ; Swapnajeet Sahoo [Inde] | Psychiatric implications of the use of hydroxychloroquine in COVID-19 patients. |
| 000844 (2020) |
Anwar M. Hashem [Arabie saoudite] ; Badrah S. Alghamdi [Arabie saoudite] ; Abdullah A. Algaissi [Arabie saoudite] ; Fahad S. Alshehri [Arabie saoudite] ; Abdullah Bukhari [Arabie saoudite] ; Mohamed A. Alfaleh [Arabie saoudite] ; Ziad A. Memish [États-Unis] | Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review. |
| 000849 (2020) |
Awadhesh Kumar Singh [Inde] ; Akriti Singh [Inde] ; Altamash Shaikh [Inde] ; Ritu Singh [Inde] ; Anoop Misra [Inde] | Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries. |
| 000858 (2020) |
Philippe Gautret [France] ; Jean-Christophe Lagier [France] ; Philippe Parola [France] ; Van Thuan Hoang [Viêt Nam] ; Line Meddeb [France] ; Jacques Sevestre [France] ; Morgane Mailhe [France] ; Barbara Doudier [France] ; Camille Aubry [France] ; Sophie Amrane [France] ; Piseth Seng [France] ; Marie Hocquart [France] ; Carole Eldin [France] ; Julie Finance [France] ; Vera Esteves Vieira [France] ; Hervé Tissot Tissot-Dupont [France] ; Stéphane Honoré [France] ; Andreas Stein [France] ; Matthieu Million [France] ; Philippe Colson [France] ; Bernard La Scola [France] ; Véronique Veit [France] ; Alexis Jacquier [France] ; Jean-Claude Deharo [France] ; Michel Drancourt [France] ; Pierre Edouard Fournier [France] ; Jean-Marc Rolain [France] ; Philippe Brouqui [France] ; Didier Raoult [France] | Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. |
| 000864 (2020) |
Rashmi Ranjan Das [Inde] ; Bijayini Behera [Inde] ; Baijayantimala Mishra [Inde] ; Sushree Samiksha Naik [Inde] | Effect of chloroquine and hydroxychloroquine on COVID-19 virological outcomes: An updated meta-analysis. |
| 000886 (2020) |
Awadhesh Kumar Singh [Inde] ; Akriti Singh [Inde] ; Ritu Singh [Inde] ; Anoop Misra [Inde] | "Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis." |
| 000916 (2020) |
Mario Rivera-Izquierdo [Espagne] ; María Del Carmen Valero-Ubierna [Espagne] ; Juan Luis R-Delamo [Espagne] ; Miguel Ngel Fernández-García [Espagne] ; Silvia Martínez-Diz [Espagne] ; Arezu Tahery-Mahmoud [Espagne] ; Marta Rodríguez-Camacho [Espagne] ; Ana Belén Gámiz-Molina [Espagne] ; Nicolás Barba-Gyengo [Espagne] ; Pablo Gámez-Baeza [Espagne] ; Celia Cabrero-Rodríguez [Espagne] ; Pedro Antonio Guirado-Ruiz [Espagne] ; Divina Tatiana Martín-Romero [Espagne] ; Antonio Jesús Láinez-Ramos-Bossini [Espagne] ; María Rosa Sánchez-Pérez [Espagne] ; José Mancera-Romero [Espagne] ; Miguel García-Martín [Espagne] ; Luis Miguel Martín-Delosreyes [Espagne] ; Virginia Martínez-Ruiz [Espagne] ; Eladio Jiménez-Mejías [Espagne] | [Therapeutic agents tested in 238 COVID-19 hospitalized patients and their relationship with mortality]. |
| 000921 (2020) |
Saadia Ait Malek [Maroc] ; Imane El Bouchti [Maroc] | [SARS-CoV-2 infection in a patient treated by hydroxychloroquine and anti TNF α for Inflammatory Rheumatic Disease]. |
| 000933 (2020) |
Moa-Lina Haller ; Marie-Eve Brunner ; Hervé Olivier Zender | [Intensive care unit treatment for patients suffering from COVID-19: the Neuchâtel experience]. |
| 000960 (2020) |
Philip M. Carlucci [États-Unis] ; Tania Ahuja [États-Unis] ; Christopher Petrilli [États-Unis] ; Harish Rajagopalan [États-Unis] ; Simon Jones [États-Unis] ; Joseph Rahimian [États-Unis] | Zinc sulfate in combination with a zinc ionophore may improve outcomes in hospitalized COVID-19 patients. |
| 000967 (2020) |
Chunfeng Li [États-Unis] ; Genhong Cheng [États-Unis] | Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin? |
| 000977 (2020) |
Daniela Marotto [Italie] ; Piercarlo Sarzi-Puttini [Italie] | What is the role of rheumatologists in the era of COVID-19? |
| 000987 (2020) |
Pavan Kumar Samudrala [Inde] ; Pramod Kumar [Inde] ; Kamlesh Choudhary [Inde] ; Nagender Thakur [Inde] ; Gaurav Suresh Wadekar [Inde] ; Richa Dayaramani [Inde] ; Mukta Agrawal [Inde] ; Amit Alexander [Inde] | Virology, pathogenesis, diagnosis and in-line treatment of COVID-19. |
| 000988 (2020) |
Phulen Sarma [Inde] ; Hardeep Kaur [Inde] ; Harish Kumar [Inde] ; Dhruv Mahendru [Inde] ; Pramod Avti [Inde] ; Anusuya Bhattacharyya [Inde] ; Manisha Prajapat [Inde] ; Nishant Shekhar [Inde] ; Subodh Kumar [Inde] ; Rahul Singh [Inde] ; Ashutosh Singh [Inde] ; Deba Prasad Dhibar [Inde] ; Ajay Prakash [Inde] ; Bikash Medhi [Inde] | Virological and clinical cure in COVID-19 patients treated with hydroxychloroquine: A systematic review and meta-analysis. |
| 000A13 (2020) |
John R. Giudicessi [États-Unis] ; Peter A. Noseworthy [États-Unis] ; Paul A. Friedman [États-Unis] ; Michael J. Ackerman [États-Unis] | Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19). |
| 000A26 (2020) |
Marta Guillan [Espagne] ; Javier Villacieros-Alvarez [Espagne] ; Sara Bellido [Espagne] ; Concepcion Perez-Jorge Peremarch [Espagne] ; Victor M. Suarez-Vega [Espagne] ; Maria Aragones-Garcia [Espagne] ; Celina Cabrera-Rojo [Espagne] ; Jose Fernandez-Ferro [Espagne] | Unusual simultaneous cerebral infarcts in multiple arterial territories in a COVID-19 patient. |
| 000A40 (2020) |
Aaron Gazendam [Canada] ; Nicholas Nucci [Canada] ; Seper Ekhtiari [Canada] ; Chetan Gohal [Canada] ; Meng Zhu [Canada] ; Abbey Payne [Canada] ; Mohit Bhandari [Canada] | Trials and tribulations: so many potential treatments, so few answers. |
| 000A44 (2020) |
Shio-Shin Jean [Taïwan] ; Ping-Ing Lee [Taïwan] ; Po-Ren Hsueh [Taïwan] | Treatment options for COVID-19: The reality and challenges. |
| 000A66 (2020) |
Timothy A. West [Australie] ; Sameer Malik [Australie] ; Anastasios Nalpantidis [Australie] ; Tuan Tran [Australie] ; Christine Cannon [Australie] ; Deepak Bhonagiri [Australie] ; Kevin Chan [Australie] ; Elaine Cheong [Australie] ; Jenny Wan Sai Cheong [Australie] ; Winston Cheung [Australie] ; Faisal Choudhury [Australie] ; David Ernest [Australie] ; Claude S. Farah [Australie] ; Shelanah Fernando [Australie] ; Rupa Kanapathipillai [Australie] ; Mark Kol [Australie] ; Brendan Murfin [Australie] ; Haider Naqvi [Australie] ; Asim Shah [Australie] ; Atul Wagh [Australie] ; Samar Ojaimi [Australie] ; Bradley Frankum [Australie] ; Sean Riminton [Australie] ; Karuna Keat [Australie] | Tocilizumab for severe COVID-19 pneumonia: Case series of 5 Australian patients. |
| 000A77 (2020) |
James J. Dinicolantonio [Oman] ; Mark Mccarty [États-Unis] | Thrombotic complications of COVID-19 may reflect an upregulation of endothelial tissue factor expression that is contingent on activation of endosomal NADPH oxidase. |
| 000B03 (2020) |
Eugenia Quiros Roldan [Italie] ; Giorgio Biasiotto [Italie] ; Paola Magro [Italie] ; Isabella Zanella [Italie] | The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis? |
| 000B08 (2020) |
Doaa A. Abdelrheem [Égypte] ; Shimaa A. Ahmed [Égypte] ; H R Abd El-Mageed [Égypte] ; Hussein S. Mohamed [Égypte] ; Aziz A. Rahman [Bangladesh] ; Khaled N M. Elsayed [Égypte] ; Sayed A. Ahmed [Égypte] | The inhibitory effect of some natural bioactive compounds against SARS-CoV-2 main protease: insights from molecular docking analysis and molecular dynamic simulation. |
| 000B24 (2020) |
Heidi Ledford | The coronavirus outbreak could make it quicker and easier to trial drugs. |
| 000B29 (2020) |
Luis Ayerbe [Royaume-Uni] ; Carlos Risco [Espagne] ; Salma Ayis [Royaume-Uni] | The association between treatment with heparin and survival in patients with Covid-19. |
| 000B30 (2020) |
Carlo Perricone [Italie] ; Paola Triggianese [Italie] ; Elena Bartoloni [Italie] ; Giacomo Cafaro [Italie] ; Angelo F. Bonifacio [Italie] ; Roberto Bursi [Italie] ; Roberto Perricone [Italie] ; Roberto Gerli [Italie] | The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19. |
| 000B43 (2020) |
Ehud Chorin [États-Unis] ; Matthew Dai [États-Unis] ; Eric Shulman [États-Unis] ; Lalit Wadhwani [États-Unis] ; Roi Bar-Cohen [États-Unis] ; Chirag Barbhaiya [États-Unis] ; Anthony Aizer [États-Unis] ; Douglas Holmes [États-Unis] ; Scott Bernstein [États-Unis] ; Michael Spinelli [États-Unis] ; David S. Park [États-Unis] ; Larry A. Chinitz [États-Unis] ; Lior Jankelson [États-Unis] | The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin. |
| 000B47 (2020) |
François Danion [France] ; Yvon Ruch [France] ; Marion Fourtage [France] ; Charlotte Kaeuffer [France] ; Valentin Greigert [France] ; Nicolas Lefebvre [France] ; Joris Muller [France] ; Thierry Nai [France] ; Yves Hansmann [France] | The Good, the Bad, and the Hoax: When Publication Instantaneously Impacts Treatment Strategies for COVID-19. |
| 000B50 (2020) |
Gerardo Casucci [Italie] ; Domenico Acanfora [Italie] ; Raffaele Antonelli Incalzi [Italie] | The Cross-Talk between Age, Hypertension and Inflammation in COVID-19 Patients: Therapeutic Targets. |
| 000B52 (2020) |
Eoin Feeney [Irlande (pays)] ; Deborah Wallace [Irlande (pays)] ; Aoife Cotter [Irlande (pays)] ; Willard Tinago [Irlande (pays)] ; Cormac Mccarthy [Irlande (pays)] ; David Keane [Irlande (pays)] ; Rabia Hussain [Irlande (pays)] ; Elena Alvarez Barco [Irlande (pays)] ; Peter Doran [Irlande (pays)] ; Patrick Mallon [Irlande (pays)] | The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trial. |
| 000B59 (2020) |
Siri Göpel [Allemagne] ; Wolfgang Bethge [Allemagne] ; Peter Martus [Allemagne] ; Florian Kreth [Allemagne] ; Thomas Iftner [Allemagne] ; Stefanie Joos [Allemagne] ; Stefanie Döbele [Allemagne] ; Benjamin Mordmüller [Allemagne] ; Peter Kremsner [Allemagne] ; Thomas Ettrich [Allemagne] ; Thomas Seufferlein [Allemagne] ; Michael Bitzer [Allemagne] ; Nisar Malek [Allemagne] | Test and treat COVID 65 plus - Hydroxychloroquine versus placebo in early ambulatory diagnosis and treatment of older patients with COVID19: A structured summary of a study protocol for a randomised controlled trial. |
| 000B83 (2020) |
Jacques Fantini [France] ; Henri Chahinian [France] ; Nouara Yahi [France] | Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal. |
| 000B84 (2020) |
Jacques Fantini [France] ; Henri Chahinian [France] ; Nouara Yahi [France] | Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal. |
| 000B85 (2020) |
Sebastian E. Sattui [États-Unis] ; Jean W. Liew [États-Unis] ; Elizabeth R. Graef [États-Unis] ; Ariella Coler-Reilly [États-Unis] ; Francis Berenbaum [France] ; Alí Duarte-García [États-Unis] ; Carly Harrison [États-Unis] ; Maximilian F. Konig [États-Unis] ; Peter Korsten [Allemagne] ; Michael S. Putman [États-Unis] ; Philip C. Robinson [Australie] ; Emily Sirotich [Canada] ; Manuel F. Ugarte-Gil [Pérou] ; Kate Webb [Afrique du Sud, Royaume-Uni] ; Kristen J. Young [États-Unis] ; Alfred H J. Kim [États-Unis] ; Jeffrey A. Sparks [États-Unis] | Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19. |
| 000B95 (2020) |
Farzaneh Dastan [Iran] ; Seyed Alireza Nadji [Iran] ; Ali Saffaei [Iran] ; Majid Marjani [Iran] ; Afshin Moniri [Iran] ; Hamidreza Jamaati [Iran] ; Seyed Mohammadreza Hashemian [Iran] ; Parvaneh Baghaei [Iran] ; Atefeh Abedini [Iran] ; Mohammad Varahram [Iran] ; Sahar Yousefian [Iran] ; Payam Tabarsi [Iran] | Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial. |
| 000B98 (2020) |
Jacques Fantini [France] ; Coralie Di Scala [France] ; Henri Chahinian [France] ; Nouara Yahi [France] | Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection. |
| 000C03 (2020) |
Priyanka Pahan [États-Unis] ; Kalipada Pahan [États-Unis] | Smooth or Risky Revisit of an Old Malaria Drug for COVID-19? |
| 000C06 (2020) |
Hye Jin Jeong [Corée du Sud] ; Sein Min [Corée du Sud] ; Heelim Chae [Corée du Sud] ; Sarah Kim [Corée du Sud] ; Gunwoo Lee [Corée du Sud] ; Sung Keon Namgoong [Corée du Sud] ; Keunhong Jeong [Corée du Sud] | Signal amplification by reversible exchange for COVID-19 antiviral drug candidates. |
| 000C13 (2020) |
Nicholas E. Ingraham [États-Unis] ; David Boulware [États-Unis] ; Matthew A. Sparks [États-Unis] ; Timothy Schacker [États-Unis] ; Bradley Benson [États-Unis] ; Jeffrey A. Sparks [États-Unis] ; Thomas Murray [États-Unis] ; John Connett [États-Unis] ; Jeffrey G. Chipman [États-Unis] ; Anthony Charles [États-Unis] ; Christopher J. Tignanelli [États-Unis] | Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2. |
| 000C28 (2020) |
Praveen Kumar Tripathi [Inde] ; Saurabh Upadhyay [Inde] ; Manju Singh [Inde] ; Siva Raghavendhar [Inde] ; Mohit Bhardwaj [Inde] ; Pradeep Sharma [Inde] ; Ashok Kumar Patel [Inde] | Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2. |
| 000C39 (2020) |
S. Gevers [Pays-Bas] ; M S G. Kwa [Pays-Bas] ; E. Wijnans [Pays-Bas] ; C. Van Nieuwkoop [Pays-Bas] | Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19. |
| 000C41 (2020) |
Prasan Kumar Panda [Inde] ; Arkapal Bandyopadhyay [Inde] ; Budha Charan Singh [Inde] ; Bikram Moirangthem [Inde] ; Gaurav Chikara [Inde] ; Sarama Saha [Inde] ; Yogesh Arvind Bahurupi [Inde] | Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial. |
| 000C42 (2020) |
Ehsan Sekhavati [Iran] ; Fatemeh Jafari [Iran] ; Seyedahmad Seyedalinaghi [Iran] ; Saeidreza Jamalimoghadamsiahkali [Iran] ; Sara Sadr [Iran] ; Mohammad Tabarestani [Iran] ; Mohammad Pirhayati [Iran] ; Abolfazl Zendehdel [Iran] ; Navid Manafi [Iran] ; Mahboubeh Hajiabdolbaghi [Iran] ; Zahra Ahmadinejad [Iran] ; Hamid Emadi Kouchak [Iran] ; Sirous Jafari [Iran] ; Hosein Khalili [Iran] ; Mohamadreza Salehi [Iran] ; Arash Seifi [Iran] ; Fereshteh Shahmari Golestan [Iran] ; Fereshteh Ghiasvand [Iran] | Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial. |
| 000C43 (2020) |
Ashkan Emadi [États-Unis] ; Joel V. Chua [États-Unis] ; Rohit Talwani [États-Unis] ; S Ren M. Bentzen [États-Unis] ; John Baddley [États-Unis] | Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. |
| 000C65 (2020) |
Lin Wu [République populaire de Chine] ; Aislinn M. O'Kane [États-Unis] ; Hu Peng [République populaire de Chine] ; Yaguang Bi [République populaire de Chine] ; Dagmara Motriuk-Smith [États-Unis] ; Jun Ren [États-Unis] | SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management. |
| 000C72 (2020) |
Eva V. Schrezenmeier ; Gerd R. Burmester ; Kai-Uwe Eckardt ; Thomas Dörner [Allemagne] | Role for antimalarials in the management of COVID-19. |
| 000C88 (2020) |
Catherine E. Oldenburg [États-Unis] ; Thuy Doan [États-Unis] | Rigorous Randomized Controlled Trial Implementation in the Era of COVID-19. |
| 000C89 (2020) |
Xiaoxuan Sun [République populaire de Chine] ; Yicheng Ni [Belgique] ; Miaojia Zhang [République populaire de Chine] | Rheumotologitsts' view on the use of hydroxychloroquine to treat COVID-19. |
| 000D02 (2020) |
Rohit Kumar [Inde] ; Kutty Sharada Vinod [Inde] ; Ankit Mittal [Inde] ; Shreya Das Adhikari [Inde] ; Nitin Gupta [Inde] | Review of current clinical management guidelines for COVID-19 with special reference to India. |
| 000D31 (2020) |
Arjen M. Dondorp [Thaïlande, Royaume-Uni, Pays-Bas] ; Muhammad Hayat [Pakistan] ; Diptesh Aryal [Népal] ; Abi Beane [Thaïlande, Royaume-Uni, Pays-Bas] ; Marcus J. Schultz [Pays-Bas, Royaume-Uni, Thaïlande] | Respiratory Support in COVID-19 Patients, with a Focus on Resource-Limited Settings. |
